HIQA commences HTA on birth cohort testing for hepatitis C

The Health Information and Quality Authority (HIQA) has commenced work on a health technology assessment (HTA) of offering testing for the hepatitis C virus to people in Ireland born between 1965 and 1985.

The aim of the HTA is to establish the clinical- and cost-effectiveness of birth cohort testing for hepatitis C in Ireland. In addition, the assessment will estimate the budget impact of introducing a birth cohort testing programme and assess the organisational and resource implications of such a service. The HTA is scheduled to be finalised in early 2020.